Literature DB >> 16517173

Focus on prolactin as a metabolic hormone.

Nira Ben-Jonathan1, Eric R Hugo, Terry D Brandebourg, Christopher R LaPensee.   

Abstract

New information about the effects of prolactin (PRL) on metabolic processes warrants re-evaluation of the overall metabolic actions of PRL. PRL affects metabolic homeostasis by regulating key enzymes and transporters that are associated with glucose and lipid metabolism in several target organs. In the lactating mammary gland, PRL increases the production of milk proteins, lactose and lipids. In adipose tissue, PRL generally suppresses lipid storage and adipokine release. PRL supports the growth of pancreatic islets, stimulates insulin secretion and increases citrate production in the prostate. A specific case is made for PRL in the human breast and adipose tissue, where it acts as a circulating hormone and an autocrine or paracrine factor. Although the overall effects of PRL on body composition are modest and species specific, PRL might be involved in the manifestation of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517173     DOI: 10.1016/j.tem.2006.02.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  86 in total

1.  A pathway map of prolactin signaling.

Authors:  Aneesha Radhakrishnan; Rajesh Raju; Nirvana Tuladhar; Tejaswini Subbannayya; Joji Kurian Thomas; Renu Goel; Deepthi Telikicherla; Shyam Mohan Palapetta; B Abdul Rahiman; Desai Dattatraya Venkatesh; Kulkarni-Kale Urmila; H C Harsha; Premendu Prakash Mathur; T S Keshava Prasad; Akhilesh Pandey; Carrie Shemanko; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2012-06-09       Impact factor: 5.782

2.  Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment?

Authors:  Ignacio Bernabeu; Felipe F Casanueva
Journal:  Endocrine       Date:  2013-08-22       Impact factor: 3.633

3.  Prolactin's mediative role in male parenting in parentally experienced marmosets (Callithrix jacchus).

Authors:  Toni E Ziegler; Shelley L Prudom; Sofia Refetoff Zahed; A F Parlow; Fredrick Wegner
Journal:  Horm Behav       Date:  2009-08-05       Impact factor: 3.587

4.  Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients?

Authors:  Alice Albu; Suzana Florea; Simona Fica
Journal:  Endocrine       Date:  2015-06-12       Impact factor: 3.633

5.  Neuroadaptations in the striatal proteome of the rat following prolonged excessive sucrose intake.

Authors:  Selina Ahmed; Mohammed Abul Kashem; Ranjana Sarker; Eakhlas U Ahmed; Garth A Hargreaves; Iain S McGregor
Journal:  Neurochem Res       Date:  2014-03-15       Impact factor: 3.996

6.  The thyroid axis, prolactin, and exercise in humans.

Authors:  Anthony C Hackney; Ayoub Saeidi
Journal:  Curr Opin Endocr Metab Res       Date:  2019-07-05

7.  Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.

Authors:  Katarina Berinder; Thomas Nyström; Charlotte Höybye; Kerstin Hall; Anna-Lena Hulting
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

8.  Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort.

Authors:  Erica P Gunderson; Catherine Kim; Charles P Quesenberry; Santica Marcovina; David Walton; Robert A Azevedo; Gary Fox; Cathie Elmasian; Stephen Young; Nora Salvador; Michael Lum; Yvonne Crites; Joan C Lo; Xian Ning; Kathryn G Dewey
Journal:  Metabolism       Date:  2014-04-13       Impact factor: 8.694

Review 9.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

10.  BMI, apolipoprotein B/apolipoprotein A-I ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort.

Authors:  Xiao-Bing Jiang; Dong-Sheng He; Zhi-Gang Mao; Xiang Fan; Ni Lei; Bin Hu; Bing-Bing Song; Yong-Hong Zhu; Hai-Jun Wang
Journal:  Tumour Biol       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.